Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Infections Post Transplant

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

Bone Marrow Transplantation volume 19, pages 801–808 (1997)Cite this article

Abstract

In order to analyze the incidence and risk factors for invasive fungal infection (IFI) after allogeneic BMT, 142 consecutive adult BMT recipients (131 sibling donors, 11 unrelated donors) transplanted in 1989–1993 were retrospectively analyzed. There were 21 cases with definite or probable IFI (incidence 15%) (Aspergillus, 15; Candida, four; Fusarium, one; Absidia, one). The median time to the diagnosis of IFI was 136 days after BMT (range 6–466 days). Only 14% of the IFIs were found during the neutropenic period post-BMT. Of the pretransplant characteristics, hematological disease (MDS vs other) (P = 0.001) and unrelated donor (P = 0.01) were risk factors for IFI. Acute GVHD grade III–IV (P = 0.03) and extensive chronic GVHD (P = 0.0002) were also found to be significant risk factors. Only three patients with IFI (14%) became long-term survivors. Invasive fungal infections tended to develop late after BMT, were usually caused by Aspergillus sp., and were strongly associated with GVHD and its treatment. Better prophylaxis and treatment of IFI are needed. More effective prophylaxis for GVHD might decrease the risk of IFI after allogeneic BMT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

    E Jantunen, P Ruutu, L Volin, T Parkkali & T Ruutu

  2. Department of Medicine, Kuopio University Hospital, Finland

    E Jantunen & L Niskanen

  3. Laboratory Department, Helsinki University Central Hospital, Helsinki, Finland

    P Koukila-Kähkölä

Authors
  1. E Jantunen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Ruutu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Niskanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Volin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Parkkali
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Koukila-Kähkölä
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T Ruutu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jantunen, E., Ruutu, P., Niskanen, L. et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 19, 801–808 (1997). https://doi.org/10.1038/sj.bmt.1700737

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1700737

Keywords

This article is cited by

Search

Advanced search

Quick links